Skip to main content

Advertisement

SpringerLink
Log in

Local interventions for colorectal cancer metastases to liver and lung

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Colorectal cancer is a common cause of cancer-related deaths. About 1/3 of all cases present with distant metastasis, with the liver as the leading site and the lung as the most common extra-abdominal site.

Aims

It was aimed to evaluate the clinical characteristics and the outcomes of colorectal cancer patients with liver or lung metastasis who had received local treatments.

Methods

This is a retrospective, cross-sectional, and descriptive study. The study was performed with colorectal cancer patients that referred to the medical oncology clinic of a university hospital between December 2013 and August 2021.

Results

A total number of 122 patients who have received local treatments were included. Radiofrequency ablation was applied in 32 patients (26.2%), metastasis was surgically resected in 84 patients (68.9%), and stereotactic body radiotherapy was preferred in six patients (4.9%). At the first follow-up control after completion of local or multimodal treatment, no residual tumor was determined with radiological assessment in 88 patients (72.1%). The median progression-free survival (16.7 months vs 9.7 months) (p = .000) and the median overall survival (37.3 months vs 25.5 months) (p = .004) of these patients were significantly better than the patients with residual disease.

Conclusions

Local interventions that are applied to highly selected patients may improve the survival of metastatic colorectal cancer patients. A close follow-up after local therapies is important to diagnose recurrent disease because repeated local interventions may be possible to achieve better outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Our data is available if it is requested.

References

  1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Fedewa SA et al (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193. https://doi.org/10.3322/caac.21395

    Article  PubMed  Google Scholar 

  3. Kanzaki R, Inoue M, Kimura T et al (2017) Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy. Surg Today 47(9):1111–1118. https://doi.org/10.1007/s00595-017-1478-x

    Article  PubMed  Google Scholar 

  4. Treasure T (2019) CS01.01 "Hunting a ghost for 25 years – will we ever catch OMD?” - No. J Thoracic Oncol 14(10):S77. https://doi.org/10.1016/j.jtho.2019.08.184

  5. Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5

    Article  PubMed  Google Scholar 

  6. Embún R, Fiorentino F, Treasure T et al (2013) Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open 3(5). https://doi.org/10.1136/bmjopen-2013-002787

  7. Miller G, Biernacki P, Kemeny NE et al (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205(2):231–238. https://doi.org/10.1016/j.jamcollsurg.2007.04.039

    Article  PubMed  Google Scholar 

  8. Dienstmann R, Salazar R, Tabernero J (2015) Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. J Clin Oncol 33(16):1787–1796. https://doi.org/10.1200/JCO.2014.60.0213

    Article  CAS  PubMed  Google Scholar 

  9. Hong Y, Kim J, Choi YJ et al (2020) Clinical study of colorectal cancer operation: survival analysis. Korean J Clin Oncol. 16(1):3–8. https://doi.org/10.14216/kjco.20002

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hishida T, Tsuboi M, Okumura T et al (2017) Does repeated lung resection provide long-term survival for recurrent pulmonary metastases of colorectal cancer? Results of a retrospective Japanese multicenter study. Ann Thorac Surg 103(2):399–405. https://doi.org/10.1016/j.athoracsur.2016.08.084

    Article  PubMed  Google Scholar 

  11. Ruers T, Van Coevorden F, Punt CJ et al (2017) Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst 109(9). https://doi.org/10.1093/jnci/djx015

  12. Okumura T, Boku N, Hishida T et al (2017) Surgical outcome and prognostic stratification for pulmonary metastasis from colorectal cancer. Ann Thorac Surg 104(3):979–987. https://doi.org/10.1016/j.athoracsur.2017.03.021

    Article  PubMed  Google Scholar 

  13. Fukada M, Matsuhashi N, Takahashi T et al (2020) Prognostic factors in pulmonary metastasectomy and efficacy of repeat pulmonary metastasectomy from colorectal cancer. World J Surg Oncol 18(1):314. https://doi.org/10.1186/s12957-020-02076-3

    Article  PubMed  PubMed Central  Google Scholar 

  14. Treasure T, Farewell V, Macbeth F et al (2019) Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial. Trials 20(1):718. https://doi.org/10.1186/s13063-019-3837-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Van Cutsem E, Cervantes A, Adam R et al (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27(8):1386–1422. https://doi.org/10.1093/annonc/mdw235

    Article  PubMed  Google Scholar 

  16. Loree JM, Kopetz S (2017) Why a one size fits all approach to RAS might not fit colorectal cancer. J Natl Compr Canc Netw 15(4):545–547. https://doi.org/10.6004/jnccn.2017.0052

    Article  PubMed  Google Scholar 

  17. Mavros MN, Hyder O, Pulitano C et al (2013) Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model. J Surg Oncol 107(5):481–485. https://doi.org/10.1002/jso.23260

    Article  PubMed  Google Scholar 

  18. Nagashima I, Takada T, Adachi M et al (2006) Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. World J Gastroenterol 12(39):6305–6309. https://doi.org/10.3748/wjg.v12.i39.6305

    Article  PubMed  PubMed Central  Google Scholar 

  19. Konopke R, Kersting S, Distler M et al (2009) Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 29(1):89–102. https://doi.org/10.1111/j.1478-3231.2008.01845.x

    Article  PubMed  Google Scholar 

  20. Adam R, de Haas RJ, Wicherts DA et al (2008) Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26(22):3672–3680. https://doi.org/10.1200/JCO.2007.15.7297

    Article  PubMed  Google Scholar 

  21. Jaeck D, Nakano H, Bachellier P et al (2002) Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9(5):430–438. https://doi.org/10.1007/BF02557264

    Article  PubMed  Google Scholar 

  22. Nordlinger B, Vaillant JC, Guiguet M et al (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 12(7):1491–1496. https://doi.org/10.1200/JCO.1994.12.7.1491

  23. Pawlik TM, Schulick RD, Choti MA (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13(1):51–64. https://doi.org/10.1634/theoncologist.2007-0142

    Article  PubMed  Google Scholar 

  24. Pulitanò C, Bodingbauer M, Aldrighetti L et al (2012) Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection. Ann Surg Oncol 19(2):435–442. https://doi.org/10.1245/s10434-011-1902-1

    Article  PubMed  Google Scholar 

  25. Yasuno M, Uetake H, Ishiguro M et al (2019) mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival. Int J Clin Oncol 24(5):516–525. https://doi.org/10.1007/s10147-018-01393-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tang W, Ren L, Liu T et al (2020) Bevacizumab plus mFOLFOX6 versus mFOLFOX6 alone as first-line treatment for RAS mutant unresectable colorectal liver-limited metastases: the BECOME randomized controlled trial. J Clin Oncol 38(27):3175–3184. https://doi.org/10.1200/JCO.20.00174

    Article  CAS  PubMed  Google Scholar 

  27. Jawed I, Wilkerson J, Prasad V et al (2015) Colorectal cancer survival gains and novel treatment regimens: a systematic review and analysis. JAMA Oncol 1(6):787–795. https://doi.org/10.1001/jamaoncol.2015.1790

    Article  PubMed  Google Scholar 

  28. Wimmer K, Schwarz C, Szabo C et al (2017) Impact of neoadjuvant chemotherapy on clinical risk scores and survival in patients with colorectal liver metastases. Ann Surg Oncol 24(1):236–243. https://doi.org/10.1245/s10434-016-5615-3

    Article  PubMed  Google Scholar 

  29. Roberts KJ, White A, Cockbain A et al (2014) Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 101(7):856–866. https://doi.org/10.1002/bjs.9471

    Article  CAS  PubMed  Google Scholar 

  30. Yamashita S, Brudvik KW, Kopetz SE et al (2018) Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases. Ann Surg 267(3):514–520. https://doi.org/10.1097/SLA.0000000000002087

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Department of Medical Oncology, Bezmialem Vakif University, Istanbul, Turkey

    Melih Simsek, Mehmet Besiroglu, Atakan Topcu, Ayse Irem Yasin, Zehra Sucuoglu Isleyen, Mesut Seker & Haci Mehmet Turk

  2. Department of General Surgery, Bezmialem Vakif University, Istanbul, Turkey

    Adem Akcakaya

Authors
  1. Melih Simsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mehmet Besiroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adem Akcakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atakan Topcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ayse Irem Yasin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zehra Sucuoglu Isleyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mesut Seker
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Haci Mehmet Turk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melih Simsek.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simsek, M., Besiroglu, M., Akcakaya, A. et al. Local interventions for colorectal cancer metastases to liver and lung. Ir J Med Sci 192, 2635–2641 (2023). https://doi.org/10.1007/s11845-023-03340-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-023-03340-7

Keywords

Search

Navigation